Furthermore, elevated serum levels of FABP4 (>22.8 ng/ml) were correlated with stroke recurrence, in which the risk was elevated by 272% (OR=3.72 [95% CI 1.74–7.92], P<0.001) and 129% (2.29 [1.31–5.11], P=0.003), respectively. Here, FABP4 is linked to stroke disorder.